Atlas Trials

Switching From TDF to TAF vs. Maintaining TDF in Chronic Hepatitis B With Resistance to Adefovir or Entecavir.

Clinical trial NCT03241641 · COMPLETED

Trial details

NCT number
NCT03241641
Sponsor
Young-Suk Lim
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Chronic Hepatitis b
Start date
2017-10-26
Primary completion
2021-03-25
Enrollment
174

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.